North America Leading Global Electroceuticals / Bioelectric Medicine Market Owing to Higher Investments in Healthcare R&D: Fact.MR Study

Growing Aging Population Is Expected To Act In Favor Of Electroceuticals / Bioelectric Medicine Market Growth over the Coming Years and Will Provide Market Players with New Opportunities

United States, Rockville MD, Aug. 25, 2022 (GLOBE NEWSWIRE) -- This Fact.MR survey places the global electroceuticals / bioelectric medicine market valuation at US$ 24.5 billion at present and projects it to rise at a CAGR of 6.9% through 2026.

High proliferation of technology in the medical industry and growing prevalence of chronic diseases are anticipated to primarily favor electroceuticals / bioelectric medicine market growth over the coming years. Rising investments in the healthcare R&D sector, supportive government initiatives, and high incidence of cardiac & neurological disorders are also expected to complement electroceutical / bioelectric medicine demand over the years to come.

For Critical Insights on Electroceuticals / Bioelectric Medicine Market, Request a Sample Report

Electroceutical / bioelectric medicine manufacturing companies are focusing on expanding their business potential through mergers, collaborations, and partnerships that are also allowing them to enhance their research scope as well.

  • In September 2021, Nu Eyne, a Korean medical R&D organization focused on the utilization of electroceutical technology, collaborated with STMicroelectronics, a leading semiconductor manufacturer, to develop a wearable therapy device for eye care.

How Investment-worthy is the U.S. Market?

“High Spending on Research Providing Rewarding Business Opportunities”

The United States electroceuticals / bioelectric medicine market is anticipated to emerge as a highly lucrative market for key companies as well as aspiring startups owing to its developed healthcare infrastructure and rapid adoption of novel technologies. High spending on research and development activities in the country is also expected to propel electroceutical and bioelectric medicine sales in the country through 2026. Supportive government initiatives are projected to further bolster electroceutical / bioelectric medicine demand.

Demand for advanced bioelectric medicines for treatments in the United States is expected to be governed by factors such as the growing geriatric population, rising incidence of cardiovascular disorders, and high healthcare expenditure.

To learn more about Electroceuticals / Bioelectric Medicine Market, you can get in touch with our Analyst at

Key Segments Covered in the Electroceuticals / Bioelectric Medicine Industry Survey

  • By Product Type :

    • Cardiac Pacemakers & ICDs
    • Cochlear Implants
    • Spinal Cord Stimulators
    • Deep Brain Stimulators
    • Other Product Types

  • By End User :

    • Hospitals
    • Clinics
    • Ambulatory Surgical Centers
    • Other End Users
  • By Region :

    • North America
    • Latin America
    • Europe
    • APAC
    • MEA

Winning Strategy

Electroceutical / bioelectric medicine companies are expected to focus on the expansion of their research scope through collaborations and acquisitions. Key market players are expected to increase the frequency of new product launches to gain a competitive edge over others in the market.

All the key strategies adopted by market players have been mentioned in this latest market research report by analysts at Fact.MR, a market research and competitive intelligence provider.

Get Customization on Electroceuticals / Bioelectric Medicine Market Report for Specific Research Solutions

Key players in the Electroceuticals / Bioelectric Medicine Market

  • Sonova Holding AG
  • LivaNova PLC
  • Soterix Medical Inc.
  • NeuroPace Inc.
  • Stimwave LLC
  • Vomaris Innovations Inc.
  • Nevro Corporation
  • Biotronik
  • Second Sight Medical Products Inc.

Key Takeaways from Electroceuticals / Bioelectric Medicine Market Study

  • By the end of 2022, the market is projected to achieve a global market size of US$ 10.01 Bn.
  • Globally, North America accounted for over 33.5% of revenue in 2022.
  • Hardware based digital transaction management systems to dominate the market in 2022, with a revenue share of over 40.5%
  • More than 38.4% of market revenue was generated by the electronic signatures segment in 2021
  • Over 55.5% of the market revenue in 2022 will be accounted for by large enterprises.

Explore Fact.MR's Coverage on the Healthcare Domain-

OTC Cough, Cold, and Allergy Medicine Market- The global OTC cough, cold, and allergy medicine market was valued at around US$ 35 Bn in 2020, and is expected to accelerate at a CAGR of over 5.5% through 2031.

Geriatric Medicines Market- Fact.MR, a market research and competitive intelligence provider, states that the sales of geriatric medicines will reach US$ 768 Mn by the end of 2021. As per the report, geriatric medicines for cardiovascular ailments will account for 45% revenue until 2031.

OTC Herbal and Traditional Medicines Market- Skilled analysts at Fact.MR, a market research and competitive intelligence provider, have recently released a revised analysis on the global OTC herbal and traditional medicines market, which is slated to rise at a CAGR of 4% over the decade.

Traditional Chinese Medicine for Skincare Market- The global traditional Chinese medicine for skincare market is growing steadily due to the rising demand for various Chinese herbal medicines, acupuncture, and diet therapy, around the world.

Aesthetic Medicine Market- Newly-released aesthetic medicine industry analysis report by Fact.MR shows that global sales of aesthetic medicine market in 2021 was held at US$ 64.6 Bn. With 10.3%, the projected market growth during 2022 - 2032 is expected to be significantly higher than the historical growth.

Rhizoma Gastrodiae Tablets Market- The global rhizoma gastrodiae tablets market is poised to expand at over 10% CAGR during the 2021-2031 forecast period, according to a recently published report by award-winning consulting firm Fact.MR. Heavy emphasis on herbal-based and traditional medicines is anticipated to account for bulk of this expansion.

OTC Vitamins And Dietary Supplements Market- The global OTC vitamins and dietary supplements market reached a valuation of around US$ 90 Bn in 2020, and is slated to accelerate at a CAGR of 6% to top US$ 160 Bn by 2031.

Vitamin Shots Market- The global vitamin shots market is valued at US$ 577.2 million in 2022 and is predicted to expand at a CAGR of 4.9% to reach US$ 934.2 million by the end of 2032. Sales of vitamin shots accounted for nearly 20% of the global vitamins market at the end of 2021.

About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Mahendra Singh
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
Tel: +1 (628) 251-1583
Follow Us: LinkedIn | Twitter